August 2018
New CMR Training Guidelines

Guidelines for training in cardiovascular magnetic resonance (CMR) were published by the Society for Cardiovascular Magnetic Resonance (SCMR) in 2000 and updated in 2007. Since these documents were published, the clinical practice of CMR has evolved and a need arose to provide a training pathway for physicians already in practice. In response, the SCMR has developed these new training guidelines which, as before, are designed to be internationally applicable to CMR practitioners with a variety of medical backgrounds. This document was written by the Certification Committee of the SCMR which is comprised of an international group of cardiovascular radiologists, scientists, and cardiologists. 

SCMR Registry Trial Results to be Presented at ESC 

The overarching vision of the SCMR Registry is to provide a central, representative collective platform to demonstrate the diagnostic and prognostic value of CMR and how it impacts patient management. The first study from the registry, The Clinical Impact of Stress CMR Perfusion Imaging in the United States (SPINS): A Global CMR Registry Substudy will be  presented at the European Society of Cardiology Congress on August 25th as part of a Late Breaking Science Session. L ead investigator, Dr. Raymond Y. Kwong from the Harvard Medical School will present the preliminary results of this trial that aimed to evaluate the prognostic value of stress CMR in patients presenting with chest pain syndromes, in a real-world multi-center setting in the USA. Results of the study are embargoed until the start of the scientific session in which they will be presented and will be shared with members following the meeting. Thank you to Dr. Kwong, the participating sites, and Bayer and Siemens Healthcare for supporting this momentous achievement

RAPIDCMR - CMR for Developing Countries

Many of us push boundaries with complex, advanced CMR seeking new insights. But for most of the world, CMR is expensive, complex and unavailable. "RapidCMR" takes a different approach: faster, cheaper, easier, focusing on core information to change patient care: cardiac structure, function and scar. RapidCMR an international outreach collaboration aiming to deliver high quality, cost effective, focused CMR scan (volumes and gadolinium) performed in less than 20 minutes and integrated into healthcare where CMR had not been previously available - to date 4 (and growing) low middle income developing countries (LMICs). The collaboration consists of experts (cardiologists, radiologists, technologists), international societies coordinated by SCMR and industry. 

Hypertrophic Cardiomyopathy (HCM) - Why CMR
Author:  Teresa Castiello

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac condition with a prevalence of 1:500 in the general population. It is largely caused by mutations in genes encoding sarcomeric proteins, manifesting in left ventricular hypertrophy (LVH) in absence of secondary causes. CMR is very useful in the aetiology work up and can confirm the diagnosis. It can correctly distinguish acquired hypertrophic cardiomyopathy -including athletic heart- from familiar diseases, enabling appropriate requests for family screening.

JCMR Articles